Authors:
Chapel, SH
Veng-Pedersen, P
Schmidt, RL
Widness, JA
Citation: Sh. Chapel et al., Receptor-based model accounts for phlebotomy-induced changes in erythropoietin pharmacokinetics, EXP HEMATOL, 29(4), 2001, pp. 425-431
Authors:
Chapel, S
Veng-Pedersen, P
Hohl, RJ
Schmidt, RL
McGuire, EM
Widness, JA
Citation: S. Chapel et al., Changes in erythropoietin pharmacokinetics following busulfan-induced bonemarrow ablation in sheep: Evidence for bone marrow as a major erythropoietin elimination pathway, J PHARM EXP, 298(2), 2001, pp. 820-824
Authors:
Veng-Pedersen, P
Gobburu, JVS
Meyer, MC
Straughn, AB
Citation: P. Veng-pedersen et al., Carbamazepine level-A in vivo-in vitro correlation (IVIVC): A scaled convolution based predictive approach, BIOPHARM DR, 21(1), 2000, pp. 1-6
Authors:
Chapel, SH
Veng-Pedersen, P
Schmidt, RL
Widness, JA
Citation: Sh. Chapel et al., A pharmacodynamic analysis of erythropoietin-stimulated reticulocyte response in phlebotomized sheep, J PHARM EXP, 295(1), 2000, pp. 346-351
Authors:
Veng-Pedersen, P
Widness, JA
Pereira, LM
Schmidt, RL
Lowe, LS
Citation: P. Veng-pedersen et al., A comparison of nonlinear pharmacokinetics of erythropoietin in sheep and humans, BIOPHARM DR, 20(4), 1999, pp. 217-223